-
Product Insights
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Peripheral T-Cell Lymphomas (PTCL) clinical trial market research report provides an overview and top-line data relating to the clinical trials on PTCL. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number...
-
Product Insights
Gastrointestinal Stromal Tumor (GIST) Disease - Global Clinical Trials Review, H2, 2019
GlobalData's clinical trial report, “Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Gastrointestinal Stromal Tumor (GIST) clinical trials scenario. This report provides top line data relating to the clinical trials on Gastrointestinal Stromal Tumor (GIST). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status...
-
Product Insights
Bone Metastasis Disease - Global Clinical Trials Review, H2, 2019
GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Bone Metastasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Metastasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Pancreatic Ductal Adenocarcinoma Disease - Global Clinical Trials Review, H2, 2019
GlobalData's clinical trial report, “Pancreatic Ductal Adenocarcinoma Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Pancreatic Ductal Adenocarcinoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Ductal Adenocarcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type....
-
Product Insights
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H1, 2020" provides an overview of Treatment Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country...
-
Product Insights
Thyroid Cancer Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Thyroid Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Kidney Cancer (Renal Cell Cancer) Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H1, 2020" provides an overview of Kidney Cancer (Renal Cell Cancer) Clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Cancer (Renal Cell Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Small-Cell Lung Cancer Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Small-Cell Lung Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Small-Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Hodgkin Lymphoma Clinical Trial Analysis research report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials.
-
Sector Analysis
Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Neuroendocrine tumors pipeline drugs market report includes an assessment of the disease epidemiology, the leading marketed products with sales forecasts, late-to-mid-stage pipeline products with phase transition success rate (PTSR), and likelihood of approval (LoA) for neuroendocrine tumors (NET). The report also analyzes the clinical and commercial landscapes of NET, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment. Neuroendocrine neoplasms (NENs) are a group of rare, heterogeneous tumors that can develop...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.